Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| | 10-K | 10-Q | 10-K | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues: |
| International | 47.7 | 56.4 | 56.0 | 91.2 | 98.9 | 95.4 | 94.5 | 57.0 |
| Other | 594.4 | 692.5 | 622.7 | 873.1 | 1,035.0 | 841.4 | 1,167.8 | 1,007.8 |
| Total revenues | 642.1 | 748.9 | 678.7 | 964.3 | 1,133.9 | 936.8 | 1,262.3 | 1,064.8 |
| Revenue growth [+] | -5.4% | -22.3% | -27.6% | -23.6% | 6.5% | 54.3% | 140.6% | 128.4% |
| International | -14.8% | -38.2% | -41.3% | -3.5% | 73.5% | | | 275.0% |
| Cost of goods sold | 441.1 | 478.7 | 708.5 | 780.1 | 853.7 | 680.8 | 817.4 | 640.0 |
| Gross profit | 201.0 | 270.2 | -29.8 | 184.2 | 280.2 | 256.0 | 444.9 | 424.8 |
| Gross margin | 31.3% | 36.1% | -4.4% | 19.1% | 24.7% | 27.3% | 35.2% | 39.9% |
| Selling, general and administrative [+] | 300.6 | 403.8 | 390.2 | 470.0 | 598.3 | 459.5 | 388.8 | 318.5 |
| Sales and marketing | 137.8 | 154.6 | 158.1 | 227.7 | 349.6 | 228.0 | 208.2 | 177.4 |
| General and administrative | 162.8 | 249.2 | 232.1 | 242.3 | 248.7 | 231.5 | 180.6 | 141.1 |
| Research and development | 72.1 | 78.2 | 84.9 | 77.1 | 100.0 | 93.7 | 69.8 | 47.5 |
| Other operating expenses | | 2.8 | 337.7 | | -0.1 | | | |
| EBITDA [+] | -140.5 | | -802.2 | -324.7 | | -272.2 | 0.9 | 71.6 |
| EBITDA growth | -82.5% | -33.9% | 194.7% | -36177.8% | -683.8% | -366.9% | -101.9% | -239.3% |
| EBITDA margin | -21.9% | -28.7% | -118.2% | -33.7% | -36.9% | -29.1% | 0.1% | 6.7% |
| Depreciation and amortization | 31.2 | | 40.4 | 38.2 | | 25.0 | 14.6 | 12.8 |
| EBIT [+] | -171.7 | -214.6 | -842.6 | -362.9 | -418.0 | -297.2 | -13.7 | 58.8 |
| EBIT growth | -79.6% | -40.9% | 183.5% | 2548.9% | -810.9% | -430.2% | -76.5% | -195.6% |
| EBIT margin | -26.7% | -28.7% | -124.1% | -37.6% | -36.9% | -31.7% | -1.1% | 5.5% |
| Non-recurring items [+] | 54.1 | 51.4 | 370.2 | 372.9 | 7.7 | 4.5 | | |
| Asset impairment | 32.6 | 39.4 | 348.0 | 214.4 | 7.7 | | | |
| Interest expense, net [+] | 18.7 | 18.7 | 15.3 | 8.9 | 8.5 | 7.9 | 3.3 | -1.9 |
| Interest expense | 27.4 | 26.6 | 16.5 | 9.1 | 8.8 | 9.1 | 4.9 | 0.4 |
| Interest income | 8.7 | 7.9 | 1.2 | 0.2 | 0.3 | 1.2 | 1.6 | 2.3 |
| Other income (expense), net [+] | 2.9 | 9.5 | -15.0 | -10.3 | -2.1 | -2.0 | -0.7 | -0.1 |
| Other | -0.1 | 0.4 | -2.2 | 1.2 | -0.4 | | | |
| Pre-tax income | -241.6 | -275.2 | -1,243.1 | -755.0 | -436.3 | -311.6 | -17.7 | 60.6 |
| Income taxes | 0.2 | 0.8 | 12.1 | 2.1 | 3.1 | 1.6 | -9.1 | -3.0 |
| Tax rate | | | | | | | 51.4% | |
| Net income | -241.8 | -275.9 | -1,255.3 | -757.1 | -439.4 | -313.2 | -8.6 | 63.6 |
| Net margin | -37.7% | -36.8% | -185.0% | -78.5% | -38.8% | -33.4% | -0.7% | 6.0% |
| |
| Basic EPS [+] | ($0.70) | ($0.79) | ($3.89) | ($2.27) | ($1.39) | ($1.07) | ($0.03) | $0.22 |
| Growth | -82.1% | -65.3% | 265.4% | 7695.7% | -737.2% | -364.3% | -85.3% | -209.9% |
| Diluted EPS [+] | ($0.70) | ($0.79) | ($3.89) | ($2.27) | ($1.39) | ($1.07) | ($0.03) | $0.18 |
| Growth | -82.1% | -65.3% | 265.4% | 7695.7% | -857.9% | -364.3% | -85.3% | -192.4% |
| |
| Shares outstanding (basic) [+] | 346.7 | 350.4 | 322.4 | 333.9 | 317.1 | 293.9 | 295.6 | 292.5 |
| Growth | 7.5% | 5.0% | 9.7% | 12.9% | 8.4% | 33.0% | 5.3% | 4.5% |
| Shares outstanding (diluted) [+] | 346.7 | 350.4 | 322.4 | 333.9 | 317.1 | 293.9 | 295.6 | 347.9 |
| Growth | 7.5% | 5.0% | 9.7% | 12.9% | -8.8% | 33.0% | 5.3% | 24.3% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|